Medi-Weightloss is a clinic network rather than a website: 139 locations, physicians, labs drawn at your first visit, and a clear line drawn between the brand-name drugs and the compounded ones. Two things sit awkwardly against that — it will not publish a price, and it invites people through the door at ten pounds.
It Labels Brand and Compounded Properly
The medication list separates cleanly. Brand-name: Wegovy, Zepbound, phentermine and phendimetrazine. Compounded: semaglutide and tirzepatide.
This is the disclosure we keep asking for and rarely get. Most competitors either never say whether a product is compounded, or group brand names and generic descriptions into a single line — we found exactly that at Way Less Weight Loss, where “Ozempic, Wegovy and Semaglutide” share one price. Medi-Weightloss tells you which is which.
Offering both routes is genuinely useful. Someone with insurance coverage can take the approved product; someone paying cash can take the compounded one at a lower price and know that is what they are doing. Our compounded versus brand-name guide covers the trade-off.
Keeping phentermine and phendimetrazine on the menu matters too. These are older appetite suppressants, far cheaper than a GLP-1, and a clinic that stocks them can put an appropriate patient on one instead of defaulting to the expensive option. A network that only sold GLP-1s would have no reason to.
The 10-Pound Entry Bar
No BMI minimum is stated. The programme is described as accepting patients who need to lose 10 pounds or more.
Ten pounds is a long way below the criteria under which GLP-1 medications are indicated — broadly a BMI of 30 or above, or 27 or above with a weight-related condition. Those are the thresholds the registration trials enrolled on, and therefore the population the efficacy and safety data describe.
The fair reading is that these are probably two different bars. A weight-management programme reasonably accepts someone wanting to lose ten pounds — diet, exercise, behavioural support and monitoring are appropriate at almost any weight, and there is nothing wrong with that. Medication eligibility is a separate clinical decision made by a physician after the workup, and Medi-Weightloss does run one.
The problem is that the site does not draw that distinction. A visitor reads “10 pounds or more” on a page that also advertises Wegovy and Zepbound, and the natural inference is that ten pounds gets you access to the drug. It almost certainly does not, and saying so plainly would cost nothing.
If you are near that end of the range, go in expecting a conversation about whether medication is appropriate at all, and treat a quick yes as a reason to ask more questions rather than fewer. Our GLP-1 eligibility guide sets out the conventional criteria and where they come from.
139 Clinics and an Actual Workup
The network is stated at 139 locations across the US, with in-person care emphasised and the approach described as physician-supervised and evidence-based. The new patient visit includes medical history review, laboratory testing, body composition analysis and a personalised plan, and the initial assessment is free.
That workup is the strongest thing here. A great deal of this category prescribes GLP-1s from a questionnaire with no measurement at any point — we reviewed one service whose intake is advertised as two minutes. Drawing labs and measuring body composition before writing a prescription is ordinary good medicine, and it is uncommon enough here to be worth crediting.
Being physically present in 139 places also solves something telehealth cannot. Weight management involves blood pressure, measurements and physical examination, and a clinician who sees you in a room notices things a video call does not. Many locations are stated to accept insurance and HSA or FSA payment.
Two caveats on the numbers. The site gives the count as both 139 locations and “over 130” in different places — trivial, but it is the kind of drift worth noticing on a site making other quantitative claims. And “10 million pounds lost” is an aggregate with no denominator: impressive-sounding, but without knowing across how many patients and over how long, it says nothing about what you would lose.
No Price, Anywhere
Nothing is priced. Programme fees are described as varying for each individual, with prospective patients directed to call a phone number or visit a location.
For a franchise network this is more defensible than usual — locations are independently operated and pricing genuinely does vary geographically, so a single national number would be misleading. But the effect is unchanged: you cannot compare Medi-Weightloss to anything without booking an appointment, and the free assessment is where you find out.
Use it for that. The consultation costs nothing, so go in with a list: what the programme fee is, what the medication costs on top, whether you would be on brand-name or compounded, what the labs cost, and what happens to the price when the dose escalates. All five are answerable in one visit and none is on the website.
Provider Facts
| Medications offered | Brand-name Wegovy and Zepbound, compounded semaglutide and tirzepatide, plus phentermine and phendimetrazine |
|---|---|
| Brand-name or compounded | Both, and clearly labelled - the site states which products are brand-name and which are compounded |
| Consultation process | Free initial assessment; the new patient visit includes medical history, labs, body composition analysis and a personalised plan |
| Eligibility | No BMI minimum stated; described as accepting patients needing to lose 10 pounds or more, with diabetes permitted subject to physician approval |
| Provider involvement | Physician-supervised, in-person care emphasised |
| Lab requirements | Included in the new patient visit; specific panels and cost not published |
| Pharmacy fulfillment | Not published |
| Shipping frequency | Not applicable - an in-person clinic model |
| Support services | Body composition analysis, personalised planning and ongoing clinic visits |
| Membership fees | Not published - programme fees stated to vary by individual |
| Medication fees | Not published |
| Cancellation policy | Not published |
| Refund policy | Not published |
| Insurance | Many locations stated to accept insurance, with some visit types potentially covered; specific carriers not listed |
| HSA/FSA | HSA and FSA stated as welcomed at many locations |
| Availability | Stated as 139 locations across the US; specific states and cities not listed |
Pros and Cons
Pros
- States clearly which medications are brand-name and which are compounded
- Offers both routes, so coverage or cash-pay can both be accommodated
- Labs and body composition analysis at the first visit
- Physician-supervised, in-person care across 139 locations
- Free initial assessment
- Cheaper older appetite suppressants kept on the menu
- Insurance and HSA/FSA accepted at many locations
Cons
- No pricing published for anything
- A stated 10-pound entry bar sits well below GLP-1 prescribing criteria
- Does not distinguish programme eligibility from medication eligibility
- No list of states, cities or accepted insurance carriers
- “10 million pounds lost” has no denominator or timeframe
- Location count given as both 139 and “over 130”
Who It May Be Best For
A good fit if you want in-person, physician-supervised care with labs drawn before anything is prescribed, and there is a location near you.
Especially if you want the choice between approved and compounded medication made explicitly rather than decided for you — few places will lay both out and tell you which is which.
Use the free assessment as a pricing appointment. Get the programme fee, the medication cost, the lab cost and what happens at dose escalation, in writing, before enrolling.
If you are near the 10-pound end, ask directly whether you meet the criteria for a GLP-1 and what the alternative is. A programme can be right for you while the medication is not.
Alternatives
knownwell combines insurance billing with in-person obesity medicine. Way Less Weight Loss is a smaller clinic model in Illinois and Indiana. Hone Health prices its cheaper generics openly. Our GLP-1 cost guide covers what a year typically runs to.
Limitations of This Review
Based on Medi-Weightloss’s own published materials at mediweightloss.com, checked on 6 September 2026. Locations are independently operated and pricing, insurance acceptance and HSA/FSA handling are stated to vary between them, so what applies at your nearest clinic may differ from the national site. Anything marked not published means we could not find it. Our reading that programme eligibility and medication eligibility are distinct is an interpretation, offered as such — the site does not state it either way, which is the point we are making. GLP-1 indication criteria come from the approved labelling and published trial enrolment, not from Medi-Weightloss. Nothing here is medical advice.
Frequently Asked Questions
What does Medi-Weightloss cost?
Not published. Programme fees are stated to vary by individual and by location, and you are directed to call or visit. The initial assessment is free, so use it to get the full cost breakdown.
Will I get real Wegovy or a compounded copy?
Both are available and the site labels them separately — Wegovy and Zepbound as brand-name, semaglutide and tirzepatide as compounded. Which you receive depends on your clinical picture and what you are paying. Ask which one is being prescribed.
Can I get a GLP-1 if I only want to lose 10 pounds?
Probably not, and you should not assume so from the programme’s entry criterion. GLP-1s are indicated broadly at a BMI of 30 and above, or 27 with a weight-related condition. A programme can accept you while medication remains inappropriate.
Does it take insurance?
Many locations are stated to accept insurance, with some visit types potentially covered and HSA/FSA welcomed. Carriers are not listed and acceptance varies by location, so confirm with the specific clinic.
Verdict
3.4 / 5 — no pricing published; free initial assessment
A real clinical network doing real clinical work — labs, examination, physician supervision, and the clearest brand-versus-compounded labelling we have found. Held back by publishing no prices at all and by an entry criterion that invites an inference about medication access it does not correct.
The point worth carrying beyond this provider: qualifying for a weight programme and qualifying for a GLP-1 are two different decisions, and a page that advertises both at once rarely separates them. If a service tells you how easily you can enrol, that is not an answer to whether the medication is right for you — ask that question on its own.
Medical Disclaimer & Review Date
This review is general consumer information, not medical advice. GLP-1 medications are prescription drugs with serious contraindications, and whether any treatment is appropriate for you is a decision only a licensed healthcare provider who knows your medical history can make. Nothing here should be used to start, stop, or change a medication.
Details in this review come from Medi-Weightloss's own published materials as of the date below. Pricing, medication availability, state coverage, and policies in this category change frequently — verify current terms directly with the provider before purchasing.
Date reviewed: September 6, 2026